Additionally, given the opposing functions of AKT isoforms in some cancers, inhibition of pan-AKT has the potential for undesired physiological consequences on tumour growth and metastasis in cancers such as glioma, breast cancer and vascular tumours. This evidence concerns the gene AKT1 and breast cancer.